Evidence map›Paper›PMID 32340382›Full record

ArticleMolecules (Basel, Switzerland)2020

Hematite Nanoparticles from Unexpected Reaction of Ferrihydrite with Concentrated Acids for Biomedical Applications.

Afanasy V Lunin, Anna A Lizunova, Elizaveta N Mochalova, Maria N Yakovtseva, Vladimir R Cherkasov, Maxim P Nikitin, Eugene L Kolychev

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Afanasy V LuninMoscow Institute of Physics and Technology, 9 Institutskiy per., Dolgoprudny, 141700 Moscow Region, Russia.ORCID 0000-0003-1291-7847
Anna A LizunovaMoscow Institute of Physics and Technology, 9 Institutskiy per., Dolgoprudny, 141700 Moscow Region, Russia.
Elizaveta N MochalovaMoscow Institute of Physics and Technology, 9 Institutskiy per., Dolgoprudny, 141700 Moscow Region, Russia.ORCID 0000-0002-3157-7158
Maria N YakovtsevaMoscow Institute of Physics and Technology, 9 Institutskiy per., Dolgoprudny, 141700 Moscow Region, Russia.
Vladimir R CherkasovMoscow Institute of Physics and Technology, 9 Institutskiy per., Dolgoprudny, 141700 Moscow Region, Russia.
Maxim P NikitinMoscow Institute of Physics and Technology, 9 Institutskiy per., Dolgoprudny, 141700 Moscow Region, Russia.
Eugene L KolychevMoscow Institute of Physics and Technology, 9 Institutskiy per., Dolgoprudny, 141700 Moscow Region, Russia.ORCID 0000-0002-8420-5067
Moscow Institute of Physics and Technology · RU

Funding

Russian Science Foundation 18-73-10102Российский Фонд Фундаментальных Исследований (РФФИ) 19-33-70075
6 · The paper itself

Abstract

The development of synthetic ways to fabricate nanosized materials with a well-defined shape, narrow-sized distribution, and high stability is of great importance to a rapidly developing area of nanotechnology. Here, we report an unusual reaction between amorphous two-line ferrihydrite and concentrated sulfuric or other mineral and organic acids. Instead of the expected dissolution, we observed the formation of new narrow-distributed brick-red nanoparticles (NPs) of hematite. Different acids produce similar nanoparticles according to scanning (SEM) and transmission electron microscopy (TEM), selected area electron diffraction (SAED), X-ray diffraction (XRD), infrared spectroscopy (FTIR), and energy-dispersive X-ray spectroscopy (EDX). The reaction demonstrates new possibilities for the synthesis of acid-resistant iron oxide nanoparticles and shows a novel pathway for the reaction of iron hydroxide with concentrated acids. The biomedical potential of the fabricated nanoparticles is demonstrated by the functionalization of the particles with polymers, fluorescent labels, and antibodies. Three different applications are demonstrated: i) specific targeting of the red blood cells, e.g., for red blood cell (RBC)-hitchhiking; ii) cancer cell targeting in vitro; iii) infrared ex vivo bioimaging. This novel synthesis route may be useful for the development of iron oxide materials for such specificity-demanding applications such as nanosensors, imaging, and therapy.

Indexed as

Biomedical and Dental MaterialsAcidsFerric CompoundsHumansMagnetic Iron Oxide NanoparticlesSpectrum AnalysisAcidsBiomedical and Dental MaterialsFerric Compoundsferric oxyhydroxideantibodiesbioconjugationbioimagingcancer cell targetingferrihydritehematite nanoparticlesHER2/neunanoparticle synthesispolymer coatingred blood cells

Identifiers

PMID32340382
PMCPMC7221743
OpenAlexW3018961825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.